Regional Monitoring EECA
by ECUO PLWH
Showing 1-22 of 22 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps6.8198660060409.1911045010.9Krajowe Centrum ds. AIDS2016YesYesNot specified
2Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps1.6341100609656855457602016YesYesNot specified
3Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps1.7975553782060107.859229799542312015Not specifiedNot specifiedNot specified
4Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.37471000794060142.48166799237655222015Not specifiedNot specifiedNot specified
5Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps1.6511500609685258184002016YesYesNot specified
6Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.137103896060128.22173162220257.52016YesYesNot specified
7Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.13769264060128.22115441480171.622016YesYesNot specified
8Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps7.513800604502301035002015Not specifiedNot specifiedNot specified
9Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps6.6152300060396.915019845.5Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
10Republic of MoldovaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.698350103020.951673498.65IDA Foundation2015Not specifiedYesNot specified
11Republic of MoldovaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.698350103020.951673498.65IDA Foundation2016Not specifiedNot specifiedNot specified
12Republic of LatviaGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps13.09573030392.871392.872015Not specifiedNot specifiedNot specified
13GeorgiaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.6486003018162029160partnership for supply. chain management (PFSCM)2015NoYesNot specified
14Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.416716200030462.5540024975002015Not specifiedNot specifiedNot specified
15Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps11.62971800030348.89600209334Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
16Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.41672700030462.59004162502015Not specifiedNot specifiedNot specified
17Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps14.01837200030420.5524001009320Krajowe Centrum ds. AIDS2016YesYesNot specified
18Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps3.60311103030108.093701400041.092015Not specifiedNot specifiedNot specified
19Republic of BelarusGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.56671563030175218857UNDP/UNICEF2016NoNoNot specified
20Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.4167300030462.5100462502015Not specifiedNot specifiedNot specified
21Republic of BelarusGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.5667432030171442448IDA Foundation20152015-12-222016-04-14NoNoNot specified
22Republic of LatviaGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps14.83376726030445.012242997712.44National Health Service (NHC)2016Not specifiedNot specifiedNot specified